You are leaving Medscape Education
Cancel Continue
Log in to save activities Your saved activities will show here so that you can easily access them whenever you're ready. Log in here CME & Education Log in to keep track of your credits.
 

CE

The Nurse’s View: Managing Your Patient's Maintenance Therapy for Multiple Myeloma

  • Authors: Beth Faiman, PhD, CNP; Charise Gleason, MSN, NP-BC, AOCNP; Sandra Kurtin, RN, MS, AOCN, ANP-C
  • CE Released: 12/15/2018
  • THIS ACTIVITY HAS EXPIRED
  • Valid for credit through: 12/15/2019
Start Activity


Target Audience and Goal Statement

This activity is intended for nurses/nurse practitioners, hematology/oncology specialists, and other care professionals involved in the care of patients with multiple myeloma.

The goal of this activity is to improve knowledge of maintenance therapy and competence caring for patients with multiple myeloma on maintenance therapy.

Upon completion of this activity, participants will:

  • Have increased knowledge regarding the
    • Clinical safety and efficacy of agents recommended for use as maintenance therapy for multiple myeloma
  • Have greater competence related to
    • Preventing and managing treatment-related adverse effects in patients with multiple myeloma receiving maintenance therapy
    • Counseling and educating patients receiving maintenance therapy as part of the management of multiple myeloma


Disclosures

As an organization accredited by the ACCME, Medscape, LLC, requires everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse or life partner, that could create a conflict of interest.

Medscape, LLC, encourages Authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.


Moderator

  • Beth Faiman, PhD, CNP

    Nurse Practitioner
    Multiple Myeloma Program
    Taussig Cancer Institute, Cleveland Clinic
    Cleveland, Ohio

    Disclosures

    Disclosure: Beth Faiman, PhD, CNP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Amgen Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Takeda Pharmaceuticals North America, Inc.
    Served as a speaker or a member of a speakers bureau for: Amgen Inc.; Bristol-Myers Squibb Company; Celgene Corporation; Takeda Pharmaceuticals North America, Inc.
    Received grants for clinical research from: Carevive Systems, Inc.

Panelists

  • Charise Gleason, MSN, NP-BC, AOCNP

    Chief of Advance Practice Providers Department of Hematology
    and Medical Oncology
    Emory University School of Medicine Nurse Practitioner
    Bone Marrow and Stem Cell Transplant Center
    Winship Cancer Institute of Emory University
    Atlanta, Georgia

    The opinions expressed are those of Ms Charise Gleason and do not necessarily reflect the views of Emory University or Emory Healthcare. Ms Gleason’s participation in this activity does not constitute or imply endorsement by Emory University or Emory Healthcare.

    Disclosures

    Disclosure: Charise Gleason, MSN, NP-BC, AOCNP, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Takeda Pharmaceuticals North America, Inc.

  • Sandra Kurtin, RN, MS, AOCN, ANP-C

    Assistant Professor of Clinical Medicine
    Assistant Professor of Nursing
    The University of Arizona Cancer Center
    Tucson, Arizona

    Disclosures

    Disclosure: Sandra Kurtin, RN, MS, AOCN, ANP-C, has disclosed the following relevant financial relationships:
    Served as an advisor or consultant for: Celgene Corporation; Pharmacyclics, Inc.; Takeda Pharmaceuticals North America, Inc.
    Served as a speaker or a member of a speakers bureau for: AbbVie Inc.; Genentech, Inc.

Editors

  • Sara Fagerlie, PhD, CHCP

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Sara Fagerlie, PhD, CHCP, has disclosed no relevant financial relationships.

  • Melinda Tanzola, PhD

    Scientific Director, Medscape, LLC

    Disclosures

    Disclosure: Melinda Tanzola, PhD, has disclosed no relevant financial relationships.

Nurse Planner

  • Amy Bernard, MS, BSN, RN-BC, CHCP

    Lead Nurse Planner, Medscape, LLC

    Disclosures

    Disclosure: Amy Bernard, MS, BSN, RN-BC, CHCP, has disclosed no relevant financial relationships.

Peer Reviewer

This activity has been peer reviewed and the reviewer has disclosed no relevant financial relationships.


Accreditation Statements



In support of improving patient care, Medscape, LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

    For Nurses

  • Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.

    Contact This Provider

For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]


Instructions for Participation and Credit

There are no fees for participating in or receiving credit for this online educational activity. For information on applicability and acceptance of continuing education credit for this activity, please consult your professional licensing board.

This activity is designed to be completed within the time designated on the title page; physicians should claim only those credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the activity online during the valid credit period that is noted on the title page. To receive AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.

Follow these steps to earn CME/CE credit*:

  1. Read the target audience, learning objectives, and author disclosures.
  2. Study the educational content online or printed out.
  3. Online, choose the best answer to each test question. To receive a certificate, you must receive a passing score as designated at the top of the test. We encourage you to complete the Activity Evaluation to provide feedback for future programming.

You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it. Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print out the tally as well as the certificates from the CME/CE Tracker.

*The credit that you receive is based on your user profile.

CE

The Nurse’s View: Managing Your Patient's Maintenance Therapy for Multiple Myeloma

Authors: Beth Faiman, PhD, CNP; Charise Gleason, MSN, NP-BC, AOCNP; Sandra Kurtin, RN, MS, AOCN, ANP-CFaculty and Disclosures
THIS ACTIVITY HAS EXPIRED

CE Released: 12/15/2018

Valid for credit through: 12/15/2019

processing....

A Powerpoint version of the slides from this presentation
is available for use as a professional resource from Medscape Education.

  • Print